Changes in Beneficial Ownership · 4
DexCom, Inc.
DXCMNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1789416164.xml
Filing details
- Report period
- 2026-09-10
- Issuer
- DEXCOM INC
- Issuer CIK
- 0001093557
- Trading symbol
- DXCM
- Rule 10b5-1 indication
- Checked
Reporting owner 1
- Name
- Sylvain Jereme M
- Reporting owner CIK
- 0001681267
- Relationship
- Officer
- Officer title
- EVP, Chief Financal Officer
- Address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-09-10 | S · Form 4 | 3,638[F1] | D | 83.27 | 146,828[F2] | D |
Table key
- S · Form 4
- Sale on the market or privately
- D
- Direct
Footnotes
- F1
- On June 10, 2026, Mr. Sylvain adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sylvain. The shares set forth above were sold pursuant to the 10b5-1 Plan.↩ 1
- F2
- Included in this number are 87,094 unvested restricted stock units, 48,774 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 23,937 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 5,699 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 8,684 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 76 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan.↩ 1
Signature 1
- Signed
- /s/ Jereme M. Sylvain
- Date
- 2026-09-14